Comments
Loading...
Vir Biotechnology (VIR) Forecast
NewsEarningsVir Biotechnology (VIR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVir Biotechnology (NASDAQ:VIR) Stock Quotes, Forecast and News Summary
Vir Biotechnology Stock (NASDAQ: VIR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vir Biotechnology (VIR) stock?
You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.
Who are Vir Biotechnology (VIR) competitors?
Other companies in Vir Biotechnology’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Vir Biotechnology (VIR) stock?
Vir Biotechnology has a consensus price target of $31.18.
What is the current price for Vir Biotechnology (VIR)?
The stock price for Vir Biotechnology (NASDAQ: VIR) is $7.125 last updated November 22, 2024 at 10:46 AM EST.
Does Vir Biotechnology (VIR) pay a dividend?
There are no upcoming dividends for Vir Biotechnology.
When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?
Vir Biotechnology’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Vir Biotechnology (VIR) going to split?
There is no upcoming split for Vir Biotechnology.
What sector and industry does Vir Biotechnology (VIR) operate in?
Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.